Testing effectiveness (Phase 2)UnknownNCT03415867
What this trial is testing
Glasdegib in Refractory Patients With Sclerotic Chronic Graft-Versus-Host Disease
Who this might be right for
Sclerodermoid Chronic Graft-Versus-Host Disease (Disorder)
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 21